UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer

PloS one, 2024-07, Vol.19 (7), p.e0293707

2024

Volltextzugriff (PDF)

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis

Frontiers in immunology, 2021-10, Vol.12, p.768957

2021

Volltextzugriff (PDF)

Cerebrospinal Fluid Concentration of the RET Inhibitor Pralsetinib: A Case Report

Case reports in oncology, 2023-01, Vol.16 (1), p.1579-1585

2023

Volltextzugriff (PDF)

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance

Cancers, 2022-03, Vol.14 (7), p.1783

2022

Volltextzugriff (PDF)

Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

The Journal of infectious diseases, 2021-04, Vol.223 (8), p.1322-1333

2021

Volltextzugriff (PDF)

A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test

Tumor biology, 2020-09, Vol.42 (9), p.101042832095860-1010428320958603

2020

Volltextzugriff (PDF)

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

Thorax, 2014-12, Vol.69 (12), p.1098-1104

2014

Volltextzugriff (PDF)

Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer: a systematic review

Histopathology, 2020-05, Vol.76 (6), p.793-802

2020

Volltextzugriff (PDF)

Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry

European journal of immunology, 2024-01, Vol.54 (1), p.e2350616-n/a

2024

Volltextzugriff (PDF)

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden

Respiratory research, 2021-11, Vol.22 (1), p.302-302, Article 302

2021

Volltextzugriff (PDF)

A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma

European urology, 2017-06, Vol.71 (6), p.858-862

2017

Volltextzugriff (PDF)

Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study

Thorax, 2023-05, Vol.78 (5), p.467

2023

Volltextzugriff (PDF)

An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection

Clinical chemistry (Baltimore, Md.), 2021-07, Vol.67 (7), p.959-967

2021

Volltextzugriff (PDF)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

Molecular oncology, 2022-07, Vol.16 (14), p.2719-2732

2022

Volltextzugriff (PDF)

Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment

International journal of cancer, 2021-10, Vol.149 (8), p.1576-1584

2021

Volltextzugriff (PDF)

Recent Advances and Future Perspective of DC-Based Therapy in NSCLC

Frontiers in immunology, 2021-06, Vol.12, p.704776-704776

2021

Volltextzugriff (PDF)

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer

Clinical and translational science, 2022-08, Vol.15 (8), p.1916-1925

2022

Volltextzugriff (PDF)

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile

Oncoimmunology, 2019-11, Vol.8 (11), p.e1648170-e1648170

2019

Volltextzugriff (PDF)

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

Frontiers in pharmacology, 2023-11, Vol.14, p.1274532-1274532

2023

Volltextzugriff (PDF)

Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer

European respiratory review, 2022-06, Vol.31 (164), p.220004

2022

Volltextzugriff (PDF)

Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer

PloS one, 2019-05, Vol.14 (5), p.e0216864-e0216864

2019

Volltextzugriff (PDF)

Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa

JAMA network open, 2019-02, Vol.2 (2), p.e187665-e187665

2019

Volltextzugriff (PDF)

Barriers and Facilitators for Implementation of a Computerized Clinical Decision Support System in Lung Cancer Multidisciplinary Team Meetings-A Qualitative Assessment

Biology (Basel, Switzerland), 2020-12, Vol.10 (1), p.9

2020

Volltextzugriff (PDF)

CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation

Glia, 2005-09, Vol.51 (4), p.297-305

2005

Volltextzugriff (PDF)

A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions

Cancer chemotherapy and pharmacology, 2020-01, Vol.85 (1), p.231-235

2020

Volltextzugriff (PDF)

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(279)
Mit Volltextzugriff
(264)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(189)
Humans
(157)
Female
(87)
Male
(85)
Oncology
(77)
Child
(55)
Hematology
(52)
Adult
(44)
Middle Aged
(43)
Lung Cancer
(39)
Adolescent
(36)
Leukemia, Myeloid, Acute - Genetics
(36)
Child, Preschool
(35)
Mutation
(34)
Aged
(33)
Infant
(32)
Patients
(32)
Prognosis
(30)
Biological And Medical Sciences
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Head-to-head comparison of composite and individual biomarkers to predict clinical benefit to PD-1 blockade in non-small cell lung cancer

Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis

Cerebrospinal Fluid Concentration of the RET Inhibitor Pralsetinib: A Case Report

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance

Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test

Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score

Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer: a systematic review

Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry

Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden

A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma

Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study

An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment

Recent Advances and Future Perspective of DC-Based Therapy in NSCLC

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer

Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer

Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa

Barriers and Facilitators for Implementation of a Computerized Clinical Decision Support System in Lung Cancer Multidisciplinary Team Meetings-A Qualitative Assessment

CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation

A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions

Suchergebnisse filtern